In an autocrine fashion, tumor-derived IL-8 facilitates oncogenic signaling, angiogenesis, epithelial-to-mesenchymal transition (EMT) [31], acquisition of stem-cell traits, resistance to therapy, and pro-metastatic features of cancer cells [13, 14, 17, 32]. The gene discussed is CXCL8; the disease is neoplasm.